AngioWaveNet vs Autoplaque
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your primary need is to enhance the clarity and visibility of blood vessels during or immediately after cardiac catheterization procedures. This AI software is ideal for cath labs seeking to improve real-time fluoroscopic angiogram visualization, integrating seamlessly with existing workflows and any angiography system to aid interventionalists in navigating complex interventions with improved confidence and precision.
View AngioWaveNet →Choose Autoplaque if…
Choose Autoplaque if your focus is on comprehensive, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is best suited for diagnostic settings where precise measurements of plaque burden and stenosis are crucial for heart attack risk prediction and guiding long-term treatment strategies.
View Autoplaque →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Autoplaque |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Unknown |
| Deployment | Cloud-based or on-premise/servers | Workstation-based post-processing application, runs on Windows or Mac OS. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet prioritizes seamless integration into existing Cath lab workflows and is vendor-agnostic, functioning as a DICOM endpoint. It also states that minimal training is required, suggesting a lower barrier to adoption and ease of use within a complex clinical environment.
Clinical Value
AutoplaqueWhile both are FDA-cleared and clinically valuable, Autoplaque offers quantitative analysis of coronary plaques and luminal stenoses for heart attack risk prediction and treatment guidance, backed by extensive peer-reviewed publications and multicenter trials. This provides a definitive, prognostic value beyond enhanced visualization.
Pricing & Value
AngioWaveNetAngioWaveNet offers transparent pricing models, including annual licensing or subscription-based access, tailored to Cath lab volume and hospital needs. In contrast, Autoplaque's pricing is not disclosed, making it difficult for potential buyers to assess its value proposition or budget effectively.
Enterprise Readiness
AngioWaveNetAngioWaveNet offers flexible deployment options (cloud or on-premise), vendor-agnostic compatibility, DICOM endpoint functionality, and explicit HIPAA compliance with extensive cybersecurity testing. These features are crucial for integration into diverse hospital IT infrastructures.
Innovation
AngioWaveNetAngioWaveNet introduces 'AI-powered Spatiotemporal Enhancement Processing (STEPu2122)' to enhance fluoroscopic angiograms, bringing significant innovation to a 'mature technology' that has seen little advancement in two decades. This deep-learning approach reveals vessel details previously not visible.
Support & Docs
AngioWaveNetAngioWaveNet's FAQ section explicitly mentions that minimal training is required and support is available for installation, along with a contact form for inquiries. While Autoplaque has a user manual mentioned in FDA documents and a contact option, AngioWaveNet provides slightly more direct information regarding user assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Autoplaque |
|---|---|---|
| Name | AngioWaveNet | Autoplaque |
| Company | Angiowave Imaging | Cedars-Sinai Medical Center: AIM |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. |
| Primary Function | Enhances fluoroscopic angiograms for improved vessel visualization | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images |
| Specialties | Cardiology, Interventional Radiology, Vascular Surgery | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Autoplaque.